John Lewicki
Chief Tech/Sci/R&D Officer en MEREO BIOPHARMA GROUP PLC .
Fortuna: 2 402 $ al 31/03/2024
Perfil
John A.
Lewicki is currently the Chief Scientific Officer at Mereo BioPharma Group Plc since 2020.
Prior to this, he worked at OncoMed Pharmaceuticals, Inc. as the President, Chief Executive Officer & Director from 2018 to 2019.
He also worked at Scios, Inc. as a Principal from 1983 to 2000.
Dr. Lewicki holds a doctorate degree from the University of California San Diego.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/01/2024 | 3 640 ( 0.00% ) | 2 402 $ | 31/03/2024 |
Cargos activos de John Lewicki
| Empresas | Cargo | Inicio |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Chief Tech/Sci/R&D Officer | 01/07/2020 |
Antiguos cargos conocidos de John Lewicki.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Chief Executive Officer | 23/04/2019 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | - |
Formación de John Lewicki.
| University of California San Diego | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John Lewicki
